The National Institute for Health and Care Excellence (NICE) has approved the new procedure, called bronchial thermoplasty, offered to adults with severe asthma for wider use on the NHS network.

In its draft guidance, NICE noted that the procedure is safe and can reduce the severity and frequency of attacks.

It will be offered to patients with asthma that cannot be controlled with inhaler medication.

“The independent committee recommends this procedure to be carried out under standard arrangements and will take place only in specialist centres with intensive care.”

Asthma is a long-term condition that causes inflammation and constriction of the smooth muscle in the airway walls with symptoms such as recurring episodes of wheezing, breathlessness, chest-tightness and coughing.

The treatment involves the application of short pulses of radiofrequency energy to the airway wall under sedation or general anaesthetic.

It needs two sessions over a period of three weeks intervals to complete.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Bronchial thermoplasty is said to lower the ability of the airways to constrict by removing the smooth muscle mass lining them and reduce the severity and frequency of severe asthma attacks.

NICE interventional procedures programme director and clinical advisor Kevin Harris said: “If you are frequently admitted to hospital with severe asthma which cannot be controlled with drugs, this is a procedure which people may wish to consider after discussions with their clinician.

“Asthma is a common disease and the vast majority of patients won’t require this treatment. But for people with severe asthma this procedure could be life-changing.

“The committee was convinced it was safe enough and works well enough for use with standard arrangements in the NHS.”

Additionally, the independent committee recommends this procedure to be carried out under standard arrangements and will take place only in specialist centres with intensive care.